Glanbia ( (GLAPF) ) just unveiled an update.
Glanbia reported strong financial results for 2024, with a 6.8% growth in adjusted EPS and a 5.8% increase in group revenues, reaching $3.8 billion. The company announced a strategic transformation program to drive efficiencies and growth, targeting $50 million in cost savings by 2027. This includes a new operating model and exiting certain businesses, such as Body & Fit and SlimFast. The company also increased its dividend by 10% and authorized further share buybacks, reflecting its commitment to shareholder returns. Looking ahead, Glanbia anticipates challenges from input cost inflation but remains focused on driving performance across its nutrition brands.
More about Glanbia
Glanbia is a global nutrition company that operates in the health and wellness industry, focusing on performance nutrition, health and nutrition, and dairy nutrition. The company is known for its portfolio of better nutrition brands and ingredients, including Optimum Nutrition and Isopure, and has a significant market presence in nutritional solutions and US cheese.
YTD Price Performance: 6.31%
Average Trading Volume: 576
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $3.91B
See more insights into GLAPF stock on TipRanks’ Stock Analysis page.